Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3365 results

Sort By:

Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients with ESRD

Study ID: NCT06878560
Start Date: 2025-06
End Date: 2028-06-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

50

Intervention / Treatment

10 GE Xenokidney

Sponsor

United Therapeutics

Source: clinicaltrials.gov

Share:
Add to list

Feasibility Testing of a Tai Chi Program for Chemotherapy-Induced Peripheral Neuropathy Treatment (TCT)

Study ID: NCT06807294
Start Date: 2025-07
End Date: 2025-10-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

21

Intervention / Treatment

Tai Chi Program

Sponsor

Dana-Farber Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list

Bridging the Treatment Gap by Expanding Access to Care for People with Epilepsy in Kenya (BEACON)

Study ID: NCT06623994
Start Date: 2025-06
End Date: 2029-08
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

530

Intervention / Treatment

Task sharing with Epilepsy Medical Record Systems

Sponsor

Indiana University

Source: clinicaltrials.gov

Share:
Add to list

Pattern and Short Term Outcomes of Renal Affection in Patients With Liver Cirrhosis in Al-Rajhi Liver Hospital

Study ID: NCT06924294
Start Date: 2025-06-01
End Date: 2025-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

290

Intervention / Treatment

observation of renal affection in patients with liver cirrhosis

Sponsor

Assiut University

Source: clinicaltrials.gov

Share:
Add to list

Using Immersive Virtual Reality for Cognitive Therapy in Elderly with Mild Cognitive Impairment

Study ID: NCT06838494
Start Date: 2025-07-03
End Date: 2027-04-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

66

Intervention / Treatment

IVR-CST (Immersive Virtual Reality Cognitive Stimulation Therapy)

Intervention Name: Conventional CST (Cognitive Stimulation Therapy)

Sponsor

The Hong Kong Polytechnic University

Source: clinicaltrials.gov

Share:
Add to list

A Study on Exploring the Abscopal Effect Induced by Different Radioimmunotherapy Combination Patterns in the Treatment of Non-Small Cell Lung Cancer With Multiple Metastases

Study ID: NCT06947694
Start Date: 2025-05-20
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

427

Intervention / Treatment

chemotherapy + PD-1 inhibitors

chemotherapy + PD-1 inhibitors

chemotherapy + PD-1 inhibitors

chemotherapy + PD-1 inhibitors

chemotherapy + PD-1 inhibitors

chemotherapy + PD-1 inhibitors

chemotherapy + PD-1 inhibitors

Sponsor

Xinqiao Hospital of Chongqing

Source: clinicaltrials.gov

Share:
Add to list

Terazosin for Dementia with Lewy Bodies

Study ID: NCT04760860
Start Date: 2026-10
End Date: 2028-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

40

Intervention / Treatment

Terazosin Hydrochloride

Placebo

Sponsor

Q iang Zhang

Source: clinicaltrials.gov

Share:
Add to list

A Nutrition & Exercise Prehabilitation Intervention on Inflammatory Biomarkers in AI Cancer Patients

Study ID: NCT06644560
Start Date: 2025-06-01
End Date: 2028-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Prehabilitation Intervention

Sponsor

University of Arizona

Source: clinicaltrials.gov

Share:
Add to list

Validity and Reliability of the Kinesthetic Motor Imagery of Pelvic Floor Muscle Contraction Questionnaire in Turkish

Study ID: NCT06882694
Start Date: 2025-10-25
End Date: 2025-12-26
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

150

Intervention / Treatment

Pelvic Floor Imagery Questionairre

Sponsor

Kutahya Health Sciences University

Source: clinicaltrials.gov

Share:
Add to list

First in Human Trial to Assess the Feasibility and Preliminary Safety of Adjunctive Treatment with the HemoSystem REBOOT in Critically Ill Patients with Sepsis-induced Immunosuppression

Study ID: NCT06258291
Start Date: 2025-09-01
End Date: 2026-12-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

16

Intervention / Treatment

Hemosystem REBOOT

Sponsor

Hemotune AG

Source: clinicaltrials.gov

Share:
Add to list